Cycling biologic therapy for severe asthma

Show other versions (1)

Bibliographic Details
Published in:	Pulmonology
Main Authors:	S. Hamada, E. Ogino, H. Yasuba
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S253104372100163X

Similar Items

Cycling biologic therapy for severe asthma
by: S. Hamada, et al.
Published: (2022-01-01)

Biologic Therapy and Severe Asthma in Children
by: Daniele Russo, et al.
Published: (2021-06-01)

Novel Biological Therapies for Severe Asthma Endotypes
by: Corrado Pelaia, et al.
Published: (2022-05-01)

Molecular Targets for Biological Therapies of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2020-11-01)

Feasibility of Discontinuing Biologics in Severe Asthma: An Algorithmic Approach
by: Hamada K, et al.
Published: (2021-12-01)

The Influence of Emphysema on Treatment Response to Biologic Therapy in Severe Asthma
by: Biener L, et al.
Published: (2024-11-01)

Economic analysis of biological therapies for severe asthma treatment
by: Carlos Almonacid-Sánchez, et al.
Published: (2019-11-01)

Biologic Therapies: Targeting Severe Asthma at the Molecular Level
by: Kamila Szewczyk, et al.
Published: (2024-06-01)

Biological therapy for severe asthma – Indian perspectives and challenges
by: Rajesh Venkitakrishnan, et al.
Published: (2023-01-01)

Early Initiation of Biologic Therapies to Prevent Severe Asthma Progression
by: Alessandra Tomasello, et al.
Published: (2025-10-01)

New perspectives of biological therapy for severe asthma in adults and adolescents
by: Chenda Chheang, et al.
Published: (2022-05-01)

Allergy immunotherapy in combination with biological therapy in moderate and severe asthma
by: Dariya S. Kulichenko, et al.
Published: (2023-08-01)

Financial burden of productivity loss in severe asthma and impact of biologic therapy
by: Kjell Erik Julius Håkansson, et al.
Published: (2025-12-01)

Targeted Biologic Therapies in Severe Asthma: Mechanisms, Biomarkers, and Clinical Applications
by: Renata Maria Văruț, et al.
Published: (2025-07-01)

Tailoring Biologic Therapies for Pediatric Severe Asthma: A Comprehensive Approach
by: Claudia María Chaverri Repáraz, et al.
Published: (2025-01-01)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
by: Shih-Lung Cheng
Published: (2021-07-01)

Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE
by: Giorgio Walter Canonica, et al.
Published: (2025-08-01)

Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry
by: Le TT, et al.
Published: (2024-10-01)

IL-18 biology in severe asthma
by: Sarita Thawanaphong, et al.
Published: (2024-11-01)

Tailored Biologics Selection in Severe Asthma
by: Sang Hyuk Kim, et al.
Published: (2024-01-01)

Severe asthma resistant to biological treatment?
by: Marta Bascuas Arribas, et al.
Published: (2024-05-01)

Managing Severe Adverse Reactions to Biologicals in Severe Asthma
by: Radu-Gheorghe Balan, et al.
Published: (2023-11-01)

Severe Asthma Questionnaire (SAQ) and Asthma Control Questionnaire (ACQ) as Early Predictors of Biologic Response in Severe Asthma
by: Davies D, et al.
Published: (2025-05-01)

Combining Dual Biologics Therapy for Severe Asthma: A Series of Ten Cases
by: Chen Y, et al.
Published: (2025-04-01)

Quality of life and work functionality in severe asthma patients: the impact of biological therapies
by: Veruscka Leso, et al.
Published: (2024-03-01)

Biologic Therapies for Moderate to Severe Asthma in the Pediatric Population: A Practice Update
by: Concettina Tolomeo DNP, MBA, APRN, FNP-BC, AE-C
Published: (2023-02-01)

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
by: Zhenan Deng, et al.
Published: (2023-01-01)

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review
by: Votto M, et al.
Published: (2021-05-01)

Definitions of non-response and response to biological therapy for severe asthma: a systematic review
by: Ekaterina Khaleva, et al.
Published: (2023-05-01)

The treatment of severe uncontrolled asthma using biologics
by: Norio Kodaka, et al.
Published: (2020-03-01)

Corrigendum: IL-18 biology in severe asthma
by: Sarita Thawanaphong, et al.
Published: (2025-01-01)

Biological treatment options for severe asthma in Poland
by: Maciej Superson, et al.
Published: (2024-05-01)

COVID-19, Eosinophils, and Biologicals for Severe Asthma
by: Carlo Lombardi, et al.
Published: (2022-04-01)

Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM study
by: Hyo-In Rhyou, MD, PhD, et al.
Published: (2024-09-01)

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2021-08-01)

Effectiveness and safety of biological therapy in patients with severe asthma in a real clinical practice
by: Galina R. Sergeeva, et al.
Published: (2024-04-01)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
by: Claudia Crimi, et al.
Published: (2023-11-01)

Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: A Finnish cohort study
by: Hannu Kankaanranta, MD, PhD, et al.
Published: (2025-05-01)

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma
by: Mobayed H, et al.
Published: (2025-05-01)

Guidance for Administering Biologics for Severe Asthma and Allergic Conditions
by: Delbert R. Dorscheid, et al.
Published: (2022-01-01)